CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop blood cancer relapse after transplant
Disease control OngoingThis study is for people with high-risk blood cancers (AML, MDS, CMML) who are getting a donor stem cell transplant. Researchers want to see if adding the drug venetoclax to standard transplant preparation and to post-transplant maintenance therapy is safe and can help prevent th…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 26, 2026 08:44 UTC
-
New hope for rare leukemia: targeted pill shows promise in early trial
Disease control OngoingThis study tests a drug called cobimetinib in people with a rare blood cancer (CMML) that has certain gene mutations. The goal is to see if the drug can shrink or control the cancer. The trial includes 14 adults who are either newly diagnosed or whose cancer stopped responding to…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated May 18, 2026 12:01 UTC